nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—CYP1A2—Anagrelide—hematologic cancer	0.111	0.217	CbGbCtD
Triamterene—CYP1A2—Carmustine—hematologic cancer	0.0582	0.114	CbGbCtD
Triamterene—CYP1A2—Methoxsalen—hematologic cancer	0.0495	0.097	CbGbCtD
Triamterene—CYP1A2—Bortezomib—hematologic cancer	0.0471	0.0922	CbGbCtD
Triamterene—CYP1A2—Daunorubicin—hematologic cancer	0.045	0.0882	CbGbCtD
Triamterene—CYP1A2—Alitretinoin—hematologic cancer	0.0441	0.0864	CbGbCtD
Triamterene—CYP1A2—Thalidomide—hematologic cancer	0.041	0.0803	CbGbCtD
Triamterene—CYP1A2—Dacarbazine—hematologic cancer	0.0353	0.0691	CbGbCtD
Triamterene—CYP1A2—Imatinib—hematologic cancer	0.0345	0.0676	CbGbCtD
Triamterene—CYP1A2—Dasatinib—hematologic cancer	0.0277	0.0543	CbGbCtD
Triamterene—CYP1A2—Etoposide—hematologic cancer	0.0173	0.0338	CbGbCtD
Triamterene—SCNN1D—gonad—hematologic cancer	0.00929	0.11	CbGeAlD
Triamterene—SCNN1B—gonad—hematologic cancer	0.00785	0.0927	CbGeAlD
Triamterene—SCNN1D—lung—hematologic cancer	0.0071	0.0838	CbGeAlD
Triamterene—SCNN1G—lung—hematologic cancer	0.0071	0.0838	CbGeAlD
Triamterene—SCNN1D—testis—hematologic cancer	0.0067	0.0791	CbGeAlD
Triamterene—SCNN1A—blood—hematologic cancer	0.00632	0.0747	CbGeAlD
Triamterene—SCNN1B—lung—hematologic cancer	0.006	0.0708	CbGeAlD
Triamterene—SCNN1B—testis—hematologic cancer	0.00566	0.0668	CbGeAlD
Triamterene—SCNN1A—lung—hematologic cancer	0.00554	0.0654	CbGeAlD
Triamterene—SCNN1A—testis—hematologic cancer	0.00523	0.0618	CbGeAlD
Triamterene—SCNN1D—lymph node—hematologic cancer	0.00486	0.0573	CbGeAlD
Triamterene—SCNN1B—lymph node—hematologic cancer	0.0041	0.0484	CbGeAlD
Triamterene—SCNN1A—lymph node—hematologic cancer	0.00379	0.0448	CbGeAlD
Triamterene—CYP1A2—hematopoietic system—hematologic cancer	0.00229	0.0271	CbGeAlD
Triamterene—SCNN1B—Ion channel transport—ATP1B1—hematologic cancer	0.00213	0.0192	CbGpPWpGaD
Triamterene—SCNN1D—Ion channel transport—ATP1B1—hematologic cancer	0.00213	0.0192	CbGpPWpGaD
Triamterene—SCNN1G—Ion channel transport—SGK1—hematologic cancer	0.00185	0.0166	CbGpPWpGaD
Triamterene—SCNN1B—Ion channel transport—SGK1—hematologic cancer	0.00185	0.0166	CbGpPWpGaD
Triamterene—SCNN1A—Ion channel transport—SGK1—hematologic cancer	0.00185	0.0166	CbGpPWpGaD
Triamterene—SCNN1D—Ion channel transport—SGK1—hematologic cancer	0.00185	0.0166	CbGpPWpGaD
Triamterene—SCNN1D—Ion channel transport—ATP4A—hematologic cancer	0.00185	0.0166	CbGpPWpGaD
Triamterene—SCNN1G—Ion channel transport—ATP4A—hematologic cancer	0.00185	0.0166	CbGpPWpGaD
Triamterene—SCNN1A—Ion channel transport—ATP4A—hematologic cancer	0.00185	0.0166	CbGpPWpGaD
Triamterene—SCNN1B—Ion channel transport—ATP4A—hematologic cancer	0.00185	0.0166	CbGpPWpGaD
Triamterene—CYP1A2—Aflatoxin B1 metabolism—EPHX1—hematologic cancer	0.00174	0.0157	CbGpPWpGaD
Triamterene—CYP1A2—blood—hematologic cancer	0.00152	0.0179	CbGeAlD
Triamterene—CYP1A2—lung—hematologic cancer	0.00133	0.0157	CbGeAlD
Triamterene—SCNN1B—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.00112	0.0101	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.00112	0.0101	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.00112	0.0101	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.00112	0.0101	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.00104	0.00936	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.00104	0.00936	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.00104	0.00936	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.00104	0.00936	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—PER3—hematologic cancer	0.000868	0.0078	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000849	0.00763	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000849	0.00763	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000849	0.00763	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000849	0.00763	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen Receptor Pathway—NR0B2—hematologic cancer	0.000805	0.00724	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.00079	0.0071	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.00079	0.0071	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.00079	0.0071	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.00079	0.0071	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000742	0.00667	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000742	0.00667	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000742	0.00667	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000742	0.00667	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—CRY2—hematologic cancer	0.000738	0.00663	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—CRY1—hematologic cancer	0.000738	0.00663	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—PER2—hematologic cancer	0.000738	0.00663	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000704	0.00632	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000704	0.00632	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000704	0.00632	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000704	0.00632	CbGpPWpGaD
Triamterene—CYP1A2—Methylation—MTR—hematologic cancer	0.000688	0.00619	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000644	0.00578	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000644	0.00578	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000644	0.00578	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000644	0.00578	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000644	0.00578	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000644	0.00578	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000644	0.00578	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000644	0.00578	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000644	0.00578	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000644	0.00578	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000644	0.00578	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000644	0.00578	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.00058	0.00521	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.00058	0.00521	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.00058	0.00521	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.00058	0.00521	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—PER1—hematologic cancer	0.000559	0.00502	CbGpPWpGaD
Triamterene—CYP1A2—Aflatoxin B1 metabolism—GSTM1—hematologic cancer	0.000555	0.00499	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000509	0.00457	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000509	0.00457	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000509	0.00457	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000509	0.00457	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen metabolism—UGT1A1—hematologic cancer	0.000496	0.00446	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000465	0.00418	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000465	0.00418	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000465	0.00418	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000465	0.00418	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000439	0.00395	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000439	0.00395	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000439	0.00395	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000439	0.00395	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000426	0.00383	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000426	0.00383	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000426	0.00383	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000426	0.00383	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000423	0.0038	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000423	0.0038	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000423	0.0038	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000423	0.0038	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000415	0.00373	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000415	0.00373	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000415	0.00373	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000415	0.00373	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	0.000401	0.00361	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—ARNTL—hematologic cancer	0.000398	0.00358	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.00037	0.00332	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.00037	0.00332	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.00037	0.00332	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.00037	0.00332	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—RET—hematologic cancer	0.000354	0.00318	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen metabolism—NQO1—hematologic cancer	0.00034	0.00306	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	0.000317	0.00285	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.00031	0.00279	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.00031	0.00279	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.00031	0.00279	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.00031	0.00279	CbGpPWpGaD
Triamterene—Diarrhoea—Melphalan—hematologic cancer	0.000284	0.000966	CcSEcCtD
Triamterene—Nausea—Chlorambucil—hematologic cancer	0.000282	0.000963	CcSEcCtD
Triamterene—Vomiting—Vinblastine—hematologic cancer	0.000277	0.000944	CcSEcCtD
Triamterene—Nausea—Nilotinib—hematologic cancer	0.000276	0.000941	CcSEcCtD
Triamterene—Diarrhoea—Lenalidomide—hematologic cancer	0.000276	0.00094	CcSEcCtD
Triamterene—Nausea—Imatinib—hematologic cancer	0.000275	0.000936	CcSEcCtD
Triamterene—Fatigue—Alitretinoin—hematologic cancer	0.000274	0.000935	CcSEcCtD
Triamterene—Hypersensitivity—Bortezomib—hematologic cancer	0.000273	0.000931	CcSEcCtD
Triamterene—Headache—Vinblastine—hematologic cancer	0.000273	0.00093	CcSEcCtD
Triamterene—Diarrhoea—Hydroxyurea—hematologic cancer	0.000272	0.000927	CcSEcCtD
Triamterene—Fatigue—Ifosfamide—hematologic cancer	0.000271	0.000924	CcSEcCtD
Triamterene—Anaphylactic shock—Cisplatin—hematologic cancer	0.000271	0.000924	CcSEcCtD
Triamterene—Hypersensitivity—Bleomycin—hematologic cancer	0.000271	0.000924	CcSEcCtD
Triamterene—Nausea—Cladribine—hematologic cancer	0.00027	0.00092	CcSEcCtD
Triamterene—Hypersensitivity—Vinorelbine—hematologic cancer	0.000267	0.000909	CcSEcCtD
Triamterene—Dizziness—Lenalidomide—hematologic cancer	0.000266	0.000908	CcSEcCtD
Triamterene—Asthenia—Bortezomib—hematologic cancer	0.000266	0.000907	CcSEcCtD
Triamterene—CYP1A2—Estrogen Receptor Pathway—ESR1—hematologic cancer	0.000266	0.00239	CbGpPWpGaD
Triamterene—Thrombocytopenia—Cisplatin—hematologic cancer	0.000265	0.000905	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—NCOR2—hematologic cancer	0.000264	0.00238	CbGpPWpGaD
Triamterene—Fatigue—Vincristine—hematologic cancer	0.000264	0.000901	CcSEcCtD
Triamterene—Asthenia—Bleomycin—hematologic cancer	0.000264	0.0009	CcSEcCtD
Triamterene—Vomiting—Melphalan—hematologic cancer	0.000263	0.000898	CcSEcCtD
Triamterene—Dizziness—Hydroxyurea—hematologic cancer	0.000263	0.000896	CcSEcCtD
Triamterene—Rash—Melphalan—hematologic cancer	0.000261	0.000891	CcSEcCtD
Triamterene—Dermatitis—Melphalan—hematologic cancer	0.000261	0.00089	CcSEcCtD
Triamterene—CYP1A2—Estrogen metabolism—GSTM1—hematologic cancer	0.000261	0.00234	CbGpPWpGaD
Triamterene—Asthenia—Vinorelbine—hematologic cancer	0.00026	0.000885	CcSEcCtD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000259	0.00233	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000259	0.00233	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000259	0.00233	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000259	0.00233	CbGpPWpGaD
Triamterene—Nausea—Vinblastine—hematologic cancer	0.000259	0.000882	CcSEcCtD
Triamterene—Hypokalaemia—Epirubicin—hematologic cancer	0.000258	0.000879	CcSEcCtD
Triamterene—Fatigue—Irinotecan—hematologic cancer	0.000257	0.000877	CcSEcCtD
Triamterene—Fatigue—Mitoxantrone—hematologic cancer	0.000257	0.000877	CcSEcCtD
Triamterene—Vomiting—Lenalidomide—hematologic cancer	0.000256	0.000873	CcSEcCtD
Triamterene—Hypersensitivity—Thiotepa—hematologic cancer	0.000255	0.000868	CcSEcCtD
Triamterene—Rash—Lenalidomide—hematologic cancer	0.000254	0.000866	CcSEcCtD
Triamterene—Dermatitis—Lenalidomide—hematologic cancer	0.000254	0.000865	CcSEcCtD
Triamterene—Diarrhoea—Bortezomib—hematologic cancer	0.000254	0.000865	CcSEcCtD
Triamterene—Vomiting—Hydroxyurea—hematologic cancer	0.000253	0.000861	CcSEcCtD
Triamterene—Headache—Lenalidomide—hematologic cancer	0.000252	0.00086	CcSEcCtD
Triamterene—Fatigue—Gemcitabine—hematologic cancer	0.000251	0.000855	CcSEcCtD
Triamterene—Rash—Hydroxyurea—hematologic cancer	0.00025	0.000854	CcSEcCtD
Triamterene—Dermatitis—Hydroxyurea—hematologic cancer	0.00025	0.000853	CcSEcCtD
Triamterene—Headache—Hydroxyurea—hematologic cancer	0.000249	0.000848	CcSEcCtD
Triamterene—Anaphylactic shock—Etoposide—hematologic cancer	0.000248	0.000847	CcSEcCtD
Triamterene—Asthenia—Thiotepa—hematologic cancer	0.000248	0.000846	CcSEcCtD
Triamterene—Diarrhoea—Vinorelbine—hematologic cancer	0.000248	0.000844	CcSEcCtD
Triamterene—Hypersensitivity—Thalidomide—hematologic cancer	0.000246	0.00084	CcSEcCtD
Triamterene—Nausea—Melphalan—hematologic cancer	0.000246	0.000839	CcSEcCtD
Triamterene—Dizziness—Bortezomib—hematologic cancer	0.000245	0.000836	CcSEcCtD
Triamterene—Anaphylactic shock—Prednisolone—hematologic cancer	0.000245	0.000835	CcSEcCtD
Triamterene—Thrombocytopenia—Etoposide—hematologic cancer	0.000243	0.000829	CcSEcCtD
Triamterene—Asthenia—Thalidomide—hematologic cancer	0.00024	0.000818	CcSEcCtD
Triamterene—Dizziness—Vinorelbine—hematologic cancer	0.000239	0.000816	CcSEcCtD
Triamterene—Nausea—Lenalidomide—hematologic cancer	0.000239	0.000816	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—NF1—hematologic cancer	0.000239	0.00215	CbGpPWpGaD
Triamterene—Photosensitivity reaction—Methotrexate—hematologic cancer	0.000239	0.000814	CcSEcCtD
Triamterene—Hypokalaemia—Doxorubicin—hematologic cancer	0.000239	0.000813	CcSEcCtD
Triamterene—Hypersensitivity—Carmustine—hematologic cancer	0.000237	0.000807	CcSEcCtD
Triamterene—Diarrhoea—Thiotepa—hematologic cancer	0.000237	0.000806	CcSEcCtD
Triamterene—Nausea—Hydroxyurea—hematologic cancer	0.000236	0.000804	CcSEcCtD
Triamterene—Vomiting—Bortezomib—hematologic cancer	0.000236	0.000804	CcSEcCtD
Triamterene—Hypersensitivity—Alitretinoin—hematologic cancer	0.000234	0.000799	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUND—hematologic cancer	0.000234	0.0021	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—UGT1A1—hematologic cancer	0.000234	0.0021	CbGpPWpGaD
Triamterene—Vomiting—Bleomycin—hematologic cancer	0.000234	0.000797	CcSEcCtD
Triamterene—Rash—Bortezomib—hematologic cancer	0.000234	0.000797	CcSEcCtD
Triamterene—Dermatitis—Bortezomib—hematologic cancer	0.000234	0.000796	CcSEcCtD
Triamterene—Headache—Bortezomib—hematologic cancer	0.000232	0.000792	CcSEcCtD
Triamterene—Rash—Bleomycin—hematologic cancer	0.000232	0.000791	CcSEcCtD
Triamterene—Dermatitis—Bleomycin—hematologic cancer	0.000232	0.00079	CcSEcCtD
Triamterene—Hypersensitivity—Ifosfamide—hematologic cancer	0.000232	0.00079	CcSEcCtD
Triamterene—Asthenia—Carmustine—hematologic cancer	0.00023	0.000785	CcSEcCtD
Triamterene—Vomiting—Vinorelbine—hematologic cancer	0.00023	0.000785	CcSEcCtD
Triamterene—CYP1A2—Phase II conjugation—SLC35B2—hematologic cancer	0.00023	0.00207	CbGpPWpGaD
Triamterene—Dry mouth—Triamcinolone—hematologic cancer	0.00023	0.000783	CcSEcCtD
Triamterene—Diarrhoea—Thalidomide—hematologic cancer	0.000229	0.00078	CcSEcCtD
Triamterene—Dizziness—Thiotepa—hematologic cancer	0.000229	0.000779	CcSEcCtD
Triamterene—Asthenia—Alitretinoin—hematologic cancer	0.000228	0.000778	CcSEcCtD
Triamterene—Rash—Vinorelbine—hematologic cancer	0.000228	0.000778	CcSEcCtD
Triamterene—Dermatitis—Vinorelbine—hematologic cancer	0.000228	0.000777	CcSEcCtD
Triamterene—Headache—Vinorelbine—hematologic cancer	0.000227	0.000773	CcSEcCtD
Triamterene—Hypersensitivity—Vincristine—hematologic cancer	0.000226	0.00077	CcSEcCtD
Triamterene—Asthenia—Ifosfamide—hematologic cancer	0.000226	0.000769	CcSEcCtD
Triamterene—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000225	0.000768	CcSEcCtD
Triamterene—Photosensitivity reaction—Epirubicin—hematologic cancer	0.000223	0.000762	CcSEcCtD
Triamterene—Dizziness—Thalidomide—hematologic cancer	0.000221	0.000754	CcSEcCtD
Triamterene—Nausea—Bortezomib—hematologic cancer	0.00022	0.000751	CcSEcCtD
Triamterene—Hypersensitivity—Irinotecan—hematologic cancer	0.00022	0.00075	CcSEcCtD
Triamterene—Hypersensitivity—Mitoxantrone—hematologic cancer	0.00022	0.00075	CcSEcCtD
Triamterene—Asthenia—Vincristine—hematologic cancer	0.00022	0.00075	CcSEcCtD
Triamterene—Vomiting—Thiotepa—hematologic cancer	0.00022	0.000749	CcSEcCtD
Triamterene—Diarrhoea—Carmustine—hematologic cancer	0.00022	0.000749	CcSEcCtD
Triamterene—Nausea—Bleomycin—hematologic cancer	0.000219	0.000745	CcSEcCtD
Triamterene—Rash—Thiotepa—hematologic cancer	0.000218	0.000743	CcSEcCtD
Triamterene—Dermatitis—Thiotepa—hematologic cancer	0.000218	0.000742	CcSEcCtD
Triamterene—Diarrhoea—Alitretinoin—hematologic cancer	0.000218	0.000742	CcSEcCtD
Triamterene—Headache—Thiotepa—hematologic cancer	0.000217	0.000738	CcSEcCtD
Triamterene—Diarrhoea—Ifosfamide—hematologic cancer	0.000215	0.000733	CcSEcCtD
Triamterene—Nausea—Vinorelbine—hematologic cancer	0.000215	0.000733	CcSEcCtD
Triamterene—Asthenia—Irinotecan—hematologic cancer	0.000214	0.00073	CcSEcCtD
Triamterene—Asthenia—Mitoxantrone—hematologic cancer	0.000214	0.00073	CcSEcCtD
Triamterene—Fatigue—Etoposide—hematologic cancer	0.000214	0.00073	CcSEcCtD
Triamterene—Jaundice—Epirubicin—hematologic cancer	0.000213	0.000725	CcSEcCtD
Triamterene—Vomiting—Thalidomide—hematologic cancer	0.000213	0.000725	CcSEcCtD
Triamterene—Dizziness—Carmustine—hematologic cancer	0.000212	0.000724	CcSEcCtD
Triamterene—Rash—Thalidomide—hematologic cancer	0.000211	0.000719	CcSEcCtD
Triamterene—Dermatitis—Thalidomide—hematologic cancer	0.000211	0.000718	CcSEcCtD
Triamterene—Dizziness—Alitretinoin—hematologic cancer	0.00021	0.000717	CcSEcCtD
Triamterene—Diarrhoea—Vincristine—hematologic cancer	0.00021	0.000715	CcSEcCtD
Triamterene—Headache—Thalidomide—hematologic cancer	0.000209	0.000714	CcSEcCtD
Triamterene—Asthenia—Gemcitabine—hematologic cancer	0.000209	0.000711	CcSEcCtD
Triamterene—Dizziness—Ifosfamide—hematologic cancer	0.000208	0.000709	CcSEcCtD
Triamterene—CYP1A2—Arachidonic acid metabolism—ALOX5—hematologic cancer	0.000208	0.00187	CbGpPWpGaD
Triamterene—Photosensitivity reaction—Doxorubicin—hematologic cancer	0.000207	0.000705	CcSEcCtD
Triamterene—Nausea—Thiotepa—hematologic cancer	0.000205	0.0007	CcSEcCtD
Triamterene—Anaphylactic shock—Betamethasone—hematologic cancer	0.000204	0.000697	CcSEcCtD
Triamterene—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000204	0.000697	CcSEcCtD
Triamterene—Diarrhoea—Irinotecan—hematologic cancer	0.000204	0.000696	CcSEcCtD
Triamterene—Diarrhoea—Mitoxantrone—hematologic cancer	0.000204	0.000696	CcSEcCtD
Triamterene—Vomiting—Carmustine—hematologic cancer	0.000204	0.000696	CcSEcCtD
Triamterene—Dizziness—Vincristine—hematologic cancer	0.000203	0.000691	CcSEcCtD
Triamterene—Rash—Carmustine—hematologic cancer	0.000202	0.00069	CcSEcCtD
Triamterene—Dermatitis—Carmustine—hematologic cancer	0.000202	0.00069	CcSEcCtD
Triamterene—Vomiting—Alitretinoin—hematologic cancer	0.000202	0.00069	CcSEcCtD
Triamterene—Headache—Carmustine—hematologic cancer	0.000201	0.000686	CcSEcCtD
Triamterene—Rash—Alitretinoin—hematologic cancer	0.000201	0.000684	CcSEcCtD
Triamterene—Dermatitis—Alitretinoin—hematologic cancer	0.0002	0.000683	CcSEcCtD
Triamterene—Thrombocytopenia—Betamethasone—hematologic cancer	0.0002	0.000682	CcSEcCtD
Triamterene—Thrombocytopenia—Dexamethasone—hematologic cancer	0.0002	0.000682	CcSEcCtD
Triamterene—Vomiting—Ifosfamide—hematologic cancer	0.0002	0.000682	CcSEcCtD
Triamterene—Hypersensitivity—Cisplatin—hematologic cancer	0.0002	0.000681	CcSEcCtD
Triamterene—Headache—Alitretinoin—hematologic cancer	0.000199	0.000679	CcSEcCtD
Triamterene—Diarrhoea—Gemcitabine—hematologic cancer	0.000199	0.000678	CcSEcCtD
Triamterene—Nausea—Thalidomide—hematologic cancer	0.000199	0.000677	CcSEcCtD
Triamterene—Rash—Ifosfamide—hematologic cancer	0.000198	0.000676	CcSEcCtD
Triamterene—Dermatitis—Ifosfamide—hematologic cancer	0.000198	0.000675	CcSEcCtD
Triamterene—Dizziness—Irinotecan—hematologic cancer	0.000197	0.000673	CcSEcCtD
Triamterene—Jaundice—Doxorubicin—hematologic cancer	0.000197	0.000671	CcSEcCtD
Triamterene—Vomiting—Vincristine—hematologic cancer	0.000195	0.000664	CcSEcCtD
Triamterene—Asthenia—Cisplatin—hematologic cancer	0.000194	0.000663	CcSEcCtD
Triamterene—Fatigue—Triamcinolone—hematologic cancer	0.000194	0.000662	CcSEcCtD
Triamterene—Rash—Vincristine—hematologic cancer	0.000193	0.000659	CcSEcCtD
Triamterene—Dermatitis—Vincristine—hematologic cancer	0.000193	0.000658	CcSEcCtD
Triamterene—Headache—Vincristine—hematologic cancer	0.000192	0.000655	CcSEcCtD
Triamterene—Nausea—Carmustine—hematologic cancer	0.000191	0.00065	CcSEcCtD
Triamterene—Vomiting—Irinotecan—hematologic cancer	0.00019	0.000647	CcSEcCtD
Triamterene—Vomiting—Mitoxantrone—hematologic cancer	0.00019	0.000647	CcSEcCtD
Triamterene—Nausea—Alitretinoin—hematologic cancer	0.000189	0.000644	CcSEcCtD
Triamterene—Rash—Mitoxantrone—hematologic cancer	0.000188	0.000642	CcSEcCtD
Triamterene—Rash—Irinotecan—hematologic cancer	0.000188	0.000642	CcSEcCtD
Triamterene—Dermatitis—Irinotecan—hematologic cancer	0.000188	0.000641	CcSEcCtD
Triamterene—Dermatitis—Mitoxantrone—hematologic cancer	0.000188	0.000641	CcSEcCtD
Triamterene—Headache—Mitoxantrone—hematologic cancer	0.000187	0.000638	CcSEcCtD
Triamterene—Headache—Irinotecan—hematologic cancer	0.000187	0.000638	CcSEcCtD
Triamterene—Nausea—Ifosfamide—hematologic cancer	0.000187	0.000637	CcSEcCtD
Triamterene—Diarrhoea—Cisplatin—hematologic cancer	0.000185	0.000632	CcSEcCtD
Triamterene—Vomiting—Gemcitabine—hematologic cancer	0.000185	0.00063	CcSEcCtD
Triamterene—Rash—Gemcitabine—hematologic cancer	0.000183	0.000625	CcSEcCtD
Triamterene—Dermatitis—Gemcitabine—hematologic cancer	0.000183	0.000625	CcSEcCtD
Triamterene—Hypersensitivity—Etoposide—hematologic cancer	0.000183	0.000624	CcSEcCtD
Triamterene—Headache—Gemcitabine—hematologic cancer	0.000182	0.000621	CcSEcCtD
Triamterene—Nausea—Vincristine—hematologic cancer	0.000182	0.000621	CcSEcCtD
Triamterene—Hypersensitivity—Prednisolone—hematologic cancer	0.00018	0.000615	CcSEcCtD
Triamterene—Asthenia—Etoposide—hematologic cancer	0.000178	0.000607	CcSEcCtD
Triamterene—Anaphylactic shock—Prednisone—hematologic cancer	0.000178	0.000607	CcSEcCtD
Triamterene—Nausea—Mitoxantrone—hematologic cancer	0.000177	0.000605	CcSEcCtD
Triamterene—Nausea—Irinotecan—hematologic cancer	0.000177	0.000605	CcSEcCtD
Triamterene—Fatigue—Betamethasone—hematologic cancer	0.000176	0.000601	CcSEcCtD
Triamterene—Fatigue—Dexamethasone—hematologic cancer	0.000176	0.000601	CcSEcCtD
Triamterene—CYP1A2—Melatonin metabolism and effects—FOXO1—hematologic cancer	0.000173	0.00156	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000173	0.00155	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000173	0.00155	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000173	0.00155	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000173	0.00155	CbGpPWpGaD
Triamterene—Nausea—Gemcitabine—hematologic cancer	0.000173	0.000589	CcSEcCtD
Triamterene—Vomiting—Cisplatin—hematologic cancer	0.000172	0.000588	CcSEcCtD
Triamterene—CYP1A2—Estrogen Receptor Pathway—JUN—hematologic cancer	0.000172	0.00154	CbGpPWpGaD
Triamterene—Rash—Cisplatin—hematologic cancer	0.000171	0.000583	CcSEcCtD
Triamterene—Dermatitis—Cisplatin—hematologic cancer	0.000171	0.000582	CcSEcCtD
Triamterene—Diarrhoea—Etoposide—hematologic cancer	0.00017	0.000579	CcSEcCtD
Triamterene—Hypersensitivity—Triamcinolone—hematologic cancer	0.000166	0.000566	CcSEcCtD
Triamterene—Dizziness—Etoposide—hematologic cancer	0.000164	0.00056	CcSEcCtD
Triamterene—Dizziness—Prednisolone—hematologic cancer	0.000162	0.000552	CcSEcCtD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000162	0.00146	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000162	0.00146	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000162	0.00146	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000162	0.00146	CbGpPWpGaD
Triamterene—Asthenia—Triamcinolone—hematologic cancer	0.000162	0.000551	CcSEcCtD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	0.000161	0.00145	CbGpPWpGaD
Triamterene—Nausea—Cisplatin—hematologic cancer	0.000161	0.000549	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—hematologic cancer	0.00016	0.00144	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—hematologic cancer	0.00016	0.00144	CbGpPWpGaD
Triamterene—Vomiting—Etoposide—hematologic cancer	0.000158	0.000538	CcSEcCtD
Triamterene—Rash—Etoposide—hematologic cancer	0.000157	0.000534	CcSEcCtD
Triamterene—Dermatitis—Etoposide—hematologic cancer	0.000156	0.000533	CcSEcCtD
Triamterene—Headache—Etoposide—hematologic cancer	0.000156	0.00053	CcSEcCtD
Triamterene—Rash—Prednisolone—hematologic cancer	0.000154	0.000526	CcSEcCtD
Triamterene—Dermatitis—Prednisolone—hematologic cancer	0.000154	0.000526	CcSEcCtD
Triamterene—Fatigue—Prednisone—hematologic cancer	0.000153	0.000523	CcSEcCtD
Triamterene—Headache—Prednisolone—hematologic cancer	0.000153	0.000523	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HSP90AA1—hematologic cancer	0.000151	0.00136	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—HSP90AA1—hematologic cancer	0.000151	0.00136	CbGpPWpGaD
Triamterene—Dizziness—Triamcinolone—hematologic cancer	0.000149	0.000508	CcSEcCtD
Triamterene—Anaphylactic shock—Methotrexate—hematologic cancer	0.000149	0.000507	CcSEcCtD
Triamterene—CYP1A2—Estrogen Receptor Pathway—STAT3—hematologic cancer	0.000149	0.00134	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTO1—hematologic cancer	0.000148	0.00133	CbGpPWpGaD
Triamterene—Nausea—Etoposide—hematologic cancer	0.000148	0.000503	CcSEcCtD
Triamterene—Asthenia—Betamethasone—hematologic cancer	0.000147	0.0005	CcSEcCtD
Triamterene—Asthenia—Dexamethasone—hematologic cancer	0.000147	0.0005	CcSEcCtD
Triamterene—Thrombocytopenia—Methotrexate—hematologic cancer	0.000146	0.000496	CcSEcCtD
Triamterene—Nausea—Prednisolone—hematologic cancer	0.000145	0.000496	CcSEcCtD
Triamterene—Vomiting—Triamcinolone—hematologic cancer	0.000143	0.000488	CcSEcCtD
Triamterene—Rash—Triamcinolone—hematologic cancer	0.000142	0.000484	CcSEcCtD
Triamterene—Dry mouth—Epirubicin—hematologic cancer	0.000142	0.000484	CcSEcCtD
Triamterene—Dermatitis—Triamcinolone—hematologic cancer	0.000142	0.000484	CcSEcCtD
Triamterene—Headache—Triamcinolone—hematologic cancer	0.000141	0.000481	CcSEcCtD
Triamterene—Diarrhoea—Betamethasone—hematologic cancer	0.00014	0.000477	CcSEcCtD
Triamterene—Diarrhoea—Dexamethasone—hematologic cancer	0.00014	0.000477	CcSEcCtD
Triamterene—CYP1A2—Phase II conjugation—UGT1A1—hematologic cancer	0.000139	0.00125	CbGpPWpGaD
Triamterene—Anaphylactic shock—Epirubicin—hematologic cancer	0.000139	0.000475	CcSEcCtD
Triamterene—Thrombocytopenia—Epirubicin—hematologic cancer	0.000136	0.000465	CcSEcCtD
Triamterene—Lamotrigine—ABCB1—hematologic cancer	0.000135	1	CrCbGaD
Triamterene—Dizziness—Betamethasone—hematologic cancer	0.000135	0.000461	CcSEcCtD
Triamterene—Dizziness—Dexamethasone—hematologic cancer	0.000135	0.000461	CcSEcCtD
Triamterene—CYP1A2—Biological oxidations—SLC35B2—hematologic cancer	0.000135	0.00121	CbGpPWpGaD
Triamterene—Nausea—Triamcinolone—hematologic cancer	0.000134	0.000456	CcSEcCtD
Triamterene—CYP1A2—Metapathway biotransformation—EPHX1—hematologic cancer	0.000133	0.00119	CbGpPWpGaD
Triamterene—Dry mouth—Doxorubicin—hematologic cancer	0.000131	0.000448	CcSEcCtD
Triamterene—Hypersensitivity—Prednisone—hematologic cancer	0.000131	0.000447	CcSEcCtD
Triamterene—Vomiting—Dexamethasone—hematologic cancer	0.00013	0.000443	CcSEcCtD
Triamterene—Vomiting—Betamethasone—hematologic cancer	0.00013	0.000443	CcSEcCtD
Triamterene—Rash—Dexamethasone—hematologic cancer	0.000129	0.000439	CcSEcCtD
Triamterene—Rash—Betamethasone—hematologic cancer	0.000129	0.000439	CcSEcCtD
Triamterene—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000129	0.000439	CcSEcCtD
Triamterene—Dermatitis—Dexamethasone—hematologic cancer	0.000129	0.000439	CcSEcCtD
Triamterene—Dermatitis—Betamethasone—hematologic cancer	0.000129	0.000439	CcSEcCtD
Triamterene—Fatigue—Methotrexate—hematologic cancer	0.000128	0.000437	CcSEcCtD
Triamterene—Headache—Betamethasone—hematologic cancer	0.000128	0.000436	CcSEcCtD
Triamterene—Headache—Dexamethasone—hematologic cancer	0.000128	0.000436	CcSEcCtD
Triamterene—Asthenia—Prednisone—hematologic cancer	0.000128	0.000435	CcSEcCtD
Triamterene—Thrombocytopenia—Doxorubicin—hematologic cancer	0.000126	0.00043	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—hematologic cancer	0.000124	0.00111	CbGpPWpGaD
Triamterene—Diarrhoea—Prednisone—hematologic cancer	0.000122	0.000415	CcSEcCtD
Triamterene—Nausea—Betamethasone—hematologic cancer	0.000121	0.000414	CcSEcCtD
Triamterene—Nausea—Dexamethasone—hematologic cancer	0.000121	0.000414	CcSEcCtD
Triamterene—CYP1A2—Phase II conjugation—MTR—hematologic cancer	0.000121	0.00109	CbGpPWpGaD
Triamterene—Fatigue—Epirubicin—hematologic cancer	0.00012	0.000409	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—hematologic cancer	0.00012	0.00108	CbGpPWpGaD
Triamterene—Dizziness—Prednisone—hematologic cancer	0.000118	0.000401	CcSEcCtD
Triamterene—CYP1A2—Phase II conjugation—GSTT1—hematologic cancer	0.000115	0.00103	CbGpPWpGaD
Triamterene—Vomiting—Prednisone—hematologic cancer	0.000113	0.000386	CcSEcCtD
Triamterene—Rash—Prednisone—hematologic cancer	0.000112	0.000383	CcSEcCtD
Triamterene—Dermatitis—Prednisone—hematologic cancer	0.000112	0.000382	CcSEcCtD
Triamterene—Headache—Prednisone—hematologic cancer	0.000112	0.00038	CcSEcCtD
Triamterene—Fatigue—Doxorubicin—hematologic cancer	0.000111	0.000379	CcSEcCtD
Triamterene—Hypersensitivity—Methotrexate—hematologic cancer	0.00011	0.000374	CcSEcCtD
Triamterene—Asthenia—Methotrexate—hematologic cancer	0.000107	0.000364	CcSEcCtD
Triamterene—Nausea—Prednisone—hematologic cancer	0.000106	0.00036	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—hematologic cancer	0.000103	0.000923	CbGpPWpGaD
Triamterene—Hypersensitivity—Epirubicin—hematologic cancer	0.000103	0.00035	CcSEcCtD
Triamterene—Diarrhoea—Methotrexate—hematologic cancer	0.000102	0.000347	CcSEcCtD
Triamterene—Asthenia—Epirubicin—hematologic cancer	9.99e-05	0.00034	CcSEcCtD
Triamterene—Dizziness—Methotrexate—hematologic cancer	9.84e-05	0.000335	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—hematologic cancer	9.66e-05	0.000868	CbGpPWpGaD
Triamterene—Diarrhoea—Epirubicin—hematologic cancer	9.53e-05	0.000325	CcSEcCtD
Triamterene—Hypersensitivity—Doxorubicin—hematologic cancer	9.49e-05	0.000324	CcSEcCtD
Triamterene—Vomiting—Methotrexate—hematologic cancer	9.46e-05	0.000322	CcSEcCtD
Triamterene—Rash—Methotrexate—hematologic cancer	9.38e-05	0.00032	CcSEcCtD
Triamterene—Dermatitis—Methotrexate—hematologic cancer	9.37e-05	0.000319	CcSEcCtD
Triamterene—Headache—Methotrexate—hematologic cancer	9.32e-05	0.000318	CcSEcCtD
Triamterene—Asthenia—Doxorubicin—hematologic cancer	9.24e-05	0.000315	CcSEcCtD
Triamterene—Dizziness—Epirubicin—hematologic cancer	9.21e-05	0.000314	CcSEcCtD
Triamterene—Vomiting—Epirubicin—hematologic cancer	8.85e-05	0.000302	CcSEcCtD
Triamterene—Nausea—Methotrexate—hematologic cancer	8.84e-05	0.000301	CcSEcCtD
Triamterene—Diarrhoea—Doxorubicin—hematologic cancer	8.81e-05	0.0003	CcSEcCtD
Triamterene—Rash—Epirubicin—hematologic cancer	8.78e-05	0.000299	CcSEcCtD
Triamterene—Dermatitis—Epirubicin—hematologic cancer	8.77e-05	0.000299	CcSEcCtD
Triamterene—Headache—Epirubicin—hematologic cancer	8.72e-05	0.000297	CcSEcCtD
Triamterene—CYP1A2—Biological oxidations—GSTO1—hematologic cancer	8.67e-05	0.000779	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTO1—hematologic cancer	8.55e-05	0.000769	CbGpPWpGaD
Triamterene—Dizziness—Doxorubicin—hematologic cancer	8.52e-05	0.00029	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—RB1—hematologic cancer	8.44e-05	0.000758	CbGpPWpGaD
Triamterene—Nausea—Epirubicin—hematologic cancer	8.27e-05	0.000282	CcSEcCtD
Triamterene—Vomiting—Doxorubicin—hematologic cancer	8.19e-05	0.000279	CcSEcCtD
Triamterene—CYP1A2—Biological oxidations—UGT1A1—hematologic cancer	8.15e-05	0.000733	CbGpPWpGaD
Triamterene—Rash—Doxorubicin—hematologic cancer	8.12e-05	0.000277	CcSEcCtD
Triamterene—Dermatitis—Doxorubicin—hematologic cancer	8.11e-05	0.000277	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—hematologic cancer	8.08e-05	0.000726	CbGpPWpGaD
Triamterene—Headache—Doxorubicin—hematologic cancer	8.07e-05	0.000275	CcSEcCtD
Triamterene—CYP1A2—Metapathway biotransformation—UGT1A1—hematologic cancer	8.04e-05	0.000723	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	8.02e-05	0.000721	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTP1—hematologic cancer	7.97e-05	0.000716	CbGpPWpGaD
Triamterene—Nausea—Doxorubicin—hematologic cancer	7.65e-05	0.000261	CcSEcCtD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	7.33e-05	0.000659	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTM1—hematologic cancer	7.32e-05	0.000658	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hematologic cancer	7.23e-05	0.00065	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—MDM2—hematologic cancer	7.19e-05	0.000647	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—MTR—hematologic cancer	7.07e-05	0.000635	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTT1—hematologic cancer	6.72e-05	0.000604	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—hematologic cancer	6.57e-05	0.00059	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—hematologic cancer	6.57e-05	0.00059	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—hematologic cancer	6.45e-05	0.00058	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hematologic cancer	6.43e-05	0.000578	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—hematologic cancer	6.25e-05	0.000562	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hematologic cancer	6.06e-05	0.000545	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—hematologic cancer	5.77e-05	0.000518	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—EP300—hematologic cancer	5.77e-05	0.000518	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—hematologic cancer	5.61e-05	0.000504	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—SRC—hematologic cancer	5.61e-05	0.000504	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—hematologic cancer	5.46e-05	0.000491	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—hematologic cancer	5.4e-05	0.000485	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	5.17e-05	0.000464	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—MYC—hematologic cancer	5.03e-05	0.000452	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hematologic cancer	5.01e-05	0.000451	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hematologic cancer	4.68e-05	0.000421	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hematologic cancer	4.68e-05	0.000421	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTP1—hematologic cancer	4.66e-05	0.000419	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—hematologic cancer	4.64e-05	0.000417	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTP1—hematologic cancer	4.6e-05	0.000413	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTM1—hematologic cancer	4.28e-05	0.000385	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTM1—hematologic cancer	4.22e-05	0.00038	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	4.21e-05	0.000379	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—hematologic cancer	3.95e-05	0.000355	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	3.68e-05	0.000331	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PHYH—hematologic cancer	3.57e-05	0.000321	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—FTCD—hematologic cancer	3.57e-05	0.000321	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GMPS—hematologic cancer	3.57e-05	0.000321	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	3.54e-05	0.000318	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	3.37e-05	0.000303	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	3.33e-05	0.000299	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SMPD3—hematologic cancer	3.27e-05	0.000294	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	3.26e-05	0.000293	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	3.05e-05	0.000274	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.97e-05	0.000267	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ASNS—hematologic cancer	2.86e-05	0.000257	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—DCK—hematologic cancer	2.86e-05	0.000257	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—B3GAT1—hematologic cancer	2.86e-05	0.000257	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.79e-05	0.000251	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HDC—hematologic cancer	2.71e-05	0.000243	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.52e-05	0.000227	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CDA—hematologic cancer	2.48e-05	0.000222	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PC—hematologic cancer	2.38e-05	0.000214	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC35B2—hematologic cancer	2.3e-05	0.000207	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GBA—hematologic cancer	2.3e-05	0.000207	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MTAP—hematologic cancer	2.1e-05	0.000189	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—FHL2—hematologic cancer	1.88e-05	0.000169	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AGRN—hematologic cancer	1.84e-05	0.000165	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—IDH2—hematologic cancer	1.74e-05	0.000157	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HMMR—hematologic cancer	1.74e-05	0.000157	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.64e-05	0.000148	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ARNTL—hematologic cancer	1.64e-05	0.000147	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ACP5—hematologic cancer	1.6e-05	0.000143	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CA9—hematologic cancer	1.6e-05	0.000143	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NCOR2—hematologic cancer	1.57e-05	0.000141	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—IDH1—hematologic cancer	1.5e-05	0.000135	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCC3—hematologic cancer	1.48e-05	0.000133	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTO1—hematologic cancer	1.48e-05	0.000133	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—TXN—hematologic cancer	1.48e-05	0.000133	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SPHK1—hematologic cancer	1.45e-05	0.00013	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—UGT1A1—hematologic cancer	1.39e-05	0.000125	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC22A1—hematologic cancer	1.36e-05	0.000122	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CRABP1—hematologic cancer	1.36e-05	0.000122	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALOX5—hematologic cancer	1.32e-05	0.000119	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NUP98—hematologic cancer	1.28e-05	0.000115	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ADCY7—hematologic cancer	1.24e-05	0.000112	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NCOA3—hematologic cancer	1.24e-05	0.000112	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NUP214—hematologic cancer	1.23e-05	0.000111	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.22e-05	0.00011	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MTR—hematologic cancer	1.21e-05	0.000109	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCG2—hematologic cancer	1.21e-05	0.000109	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ENO2—hematologic cancer	1.19e-05	0.000107	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTT1—hematologic cancer	1.15e-05	0.000103	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.13e-05	0.000102	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SDC1—hematologic cancer	1.12e-05	0.000101	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.07e-05	9.65e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.06e-05	9.52e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.01e-05	9.11e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NQO1—hematologic cancer	9.56e-06	8.59e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CD44—hematologic cancer	9.56e-06	8.59e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.36e-06	8.41e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYCS—hematologic cancer	9.04e-06	8.13e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	8.98e-06	8.08e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.09e-06	7.27e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTP1—hematologic cancer	7.97e-06	7.16e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.71e-06	6.93e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCB1—hematologic cancer	7.54e-06	6.78e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NCOR1—hematologic cancer	7.32e-06	6.58e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTM1—hematologic cancer	7.32e-06	6.58e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MTHFR—hematologic cancer	6.47e-06	5.82e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.7e-06	5.13e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CG—hematologic cancer	5.44e-06	4.89e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CREBBP—hematologic cancer	5.04e-06	4.53e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CD—hematologic cancer	4.78e-06	4.3e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALB—hematologic cancer	4.72e-06	4.24e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3R1—hematologic cancer	4.51e-06	4.06e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CB—hematologic cancer	4.17e-06	3.75e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTEN—hematologic cancer	3.6e-06	3.24e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—EP300—hematologic cancer	3.43e-06	3.09e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CA—hematologic cancer	2.54e-06	2.28e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AKT1—hematologic cancer	2.08e-06	1.87e-05	CbGpPWpGaD
